Le Lézard
Classified in: Health, Covid-19 virus
Subject: SBS

Trust Your Gut: Prevention, Not Panic Key in Curbing Coronavirus


MALIBU, Calif., March 10, 2020 /PRNewswire/ -- Dr. Sabine Hazan, Malibu-based gastroenterologist and CEO of Progenabiome, a genetic sequencing research lab, is an expert in the relationship of the gut flora (microbiome) to immunity and disease. As a microbiome research pioneer and leader in clinical trials, Hazan knows firsthand the challenges in developing treatments and vaccines for viruses. She stresses the importance of gut health and immunity in preventing the spread of the Coronavirus.

"It is time that frontline doctors seeing patients implement a unified disaster plan that includes every hospital and clinic across the country," says Dr. Hazan.  "Coronavirus trials in China and elsewhere target the virus directly. However, we must now focus on prevention."

Hazan explains that prevention begins with immunity, and immunity starts in the gut.

"A strong gut is key to Coronavirus prevention," emphasizes Hazan, "the gut directly relates to immunity, especially with at-risk groups."

The gut microbiome has trillions of bacteria, fungi and viruses that support the immune system. What you eat, how you eat, and other daily habits can significantly impact microbial symbiosis and immunity. Thus, in light of the Coronavirus outbreak, Dr. Hazan suggests avoiding sugars, heavy and refined carbs, spices, excess alcohol, artificial foods, trans fats, processed meats, and other inflammatory foods that can disturb gut balance. In addition to a bland and balanced diet, she recommends consulting your physician about adding a daily dose, preferably with food, of Vitamin C (Ascorbic Acid/3000mg), Vitamin D (2000mg+), and Zinc (50 mg.)

"This epidemic enforces the discovery of revolutionary therapies, including immune enhancement employing the gut flora," says Dr. Thomas Borody, founder of Australia-based Centre for Digestive Diseases (CDD). "This could decrease mortality in the debilitated, high-risk groups."

Dr. Hazan is investigating the role of the gut flora in immunity and disease through 33 ongoing clinical trials at Progenabiome, with oversight by the New England Independent Review Board. Progenabiome's mission is to better understand, prevent, and treat diseases by analyzing the specific genetic codes of 40 trillion gut microbes. Dr. Hazan believes the art of medicine lies in our ability to see outside the box and recognize that all microbes, like all humans, are unique.

The Coronavirus outbreak demonstrates how a single bug can mobilize the world, which reinforces the importance of understanding the gut flora and connections between the microbiome and disease.

Physicians Interested in Progenabiome's Disaster Relief Plan: Contact [email protected]

Press Inquiries:
Jolynn Regan, Progenabiome PR
[email protected]
310-508-5722

SOURCE Progenabiome


These press releases may also interest you

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...

at 17:49
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 17:33
The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the United States, announced the overwhelming success of its 2024 "Are You O-K+" campaign, which marked May 1 (5.1) as...

at 17:21
The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize cutting-edge tools to expedite antibody discovery and...

at 17:00
Zepp Health Corporation ("Zepp" or the "Company") , a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated April 30, 2024, notifying Zepp that it is...



News published on and distributed by: